Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Autors principals: Rachel S Laufer (Autor), Ranju Baral (Autor), Andrea G Buchwald (Autor), James D Campbell (Autor), Flanon Coulibaly (Autor), Fatoumata Diallo (Autor), Moussa Doumbia (Autor), Amanda J Driscoll (Autor), Alison P Galvani (Autor), Adama M Keita (Autor), Kathleen M Neuzil (Autor), Samba Sow (Autor), Clint Pecenka (Autor), Justin R Ortiz (Autor), Meagan C Fitzpatrick (Autor)
• Format: Llibre
• Publicat: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...